RAINBOW CHILDREN'S MEDICARE Q2 FY27 CONCALL: MAINTAINS HIGH-TEENS REVENUE GROWTH OUTLOOK & 25–26% PRE-IND AS EBITDA MARGIN ASPIRATION; 1,050 BEDS UNDER DEVELOPMENT, TARGETS 5,000+ BEDS LONG TERM